Mumbai-based Ideal Cures PVT LTD has received third EXCiPACT™ certificate for its main manufacturing facility at Vasai on the west coast of India.
The Vasai plant has received EXCiPACT™ certification for Film Coating Materials (INSTACOAT™, INSTANUTE™, INSTASPRAY™, and INSTAMASK™) and Extended Cooling Boosters (ECOCOOL™). With receipt of this third certificate all manufacturing plants of Ideal Cures located in India at Vasai, Jammu and Khambhat are EXCiPACT™ certified.
“All this has been made possible because of the dedication and hard work of our team. The EXCiPACT™ certification has set a bar for us to provide best quality products and technical services to our customers worldwide.”
Speaking about the news, Mr. Suresh Pareek, Managing Director of the Company said “I am very happy and proud to say that Ideal Cures becomes a trendsetter by being the first Indian company to receive EXCiPACT™ certification for all its manufacturing plants. The receipt of EXCiPACT™ certificate indicates that GMP standards are followed for manufacturing of high quality excipients. Many other Indian excipient manufacturers will follow this trend of acquiring EXCiPACT™ certification, causing overall improvement in manufacturing standards and capability of India which will eventually contribute to the ‘Make in India’ dream of our Prime Minister Shri. Narendra Modi.”
He further added, “All this has been made possible because of the dedication and hard work of our team. The EXCiPACT™ certification has set a bar for us to provide best quality products and technical services to our customers worldwide.”
EU, U.S. and pharmaceutical excipient regulations of other countries, currently require drug manufacturers to either do their own audits or rely on 3rdparty audits of all of their starting material suppliers to demonstrate GMP and/or GDP compliance. EXCiPACT™ is a high quality, voluntary international scheme that provides independent third party certification to manufacturers, suppliers and distributors of pharmaceutical excipients worldwide.
All EXCiPACT™ approved certifying bodies and their auditors have had to undergo a rigorous assessment process in order to become EXCiPACT™ Registered and to provide certification. Since the certification is international in nature, in the long run it will be a boon to the excipient manufacturers and suppliers. IDEAL CURES surely hopes to gain added trust of customers with the addition of third EXCiPACT™ certification in its basket of achievements.
Ideal Cures is an Indian company with international presence in more than 40 countries. It has has 10 granted Indian Patents and 10 pending applications.
fii-news.com
